The short interest in biotech and emerging pharmaceutical companies was mixed again in the final two weeks of February. The number of shares sold short in Alexion Pharmaceuticals (NASDAQ: ALXN ), Arena Pharmaceuticals (NASDAQ: ARNA ), Dendreon (NASDAQ: DNDN ), Gilead Sciences (NASDAQ: GILD ), Onyx